Studies demonstrated that DPP inhibition altered the CXCR3 axis and enhanced NK and CD8+ T-cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma (41). Here, CXCR3 is linked to pancreatic ductal adenocarcinoma.